According to Shenzhen Salubris Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 0,09498ย โฌ. In 2024 the company made an earnings per share (EPS) of 0,06269ย โฌ an increase over its 2023 EPS that were of 0,06233ย โฌ.